Document Type
Original Article
Abstract
Abstract: Background: Central retinal vein occlusion (CRVO) is one of the most common causes of visual loss in general population especially in middle age and elderly people. Aim: To assess the role of vitrectomy with internal limiting membrane (ILM) peeling with intravitreal ranibizumab injection for patients with CRVO with combined epiretinal membrane (ERM). Methods: The study was conducted on eleven patients with CRVO with coexisting ERM. Best corrected visual acuity (BCVA) converted into logMAR, fundus Fluorescein angiography and optical coherence tomography (OCT) assessing central macular thickness (CMT) were done. All patients had undergone vitrectomy with ILM peeling with intravitreal injection of ranibiaumab (0.5 mg/0.05 ml). Postoperatively, the patients were examined 1 week and 1 month for BCVA in logMAR and full ophthalmic examination. Also, OCT was done one month postoperatively. Results: There was a significant decrease in one week (1.064±0.258) and four weeks (0.718±0.316) postoperative BCVA in log Mar than preoperative BCVA (1.245±0.221). Also, there was a significant reduction in the four-week postoperative CMT (357.73±133.094) than preoperative CMT (497.27±225.420) (��=0.003). Conclusion: Vitrectomy combined with ILM peeling with intravitreal ranibizumab injection showed anatomical efficacy for macular edema (ME) in eyes with CRVO associated with ERM. Also, BCVA improved significantly concurrently
Keywords
Central Retinal vein occlusion; vitrectomy; Internal Limiting Membrane Peeling; ranibizumab; Epiretinal membrane
How to Cite This Article
Ali, Mahmoud
(2021)
"Vitrectomy with Internal Limiting Membrane Peeling with Intravitreal Ranibizumab Injection for Patients with Central retinal Vein Occlusion with Combined Epiretinal Membrane,"
Al-Azhar International Medical Journal: Vol. 2:
Iss.
7, Article 5.
DOI: https://doi.org/10.21608/aimj.2021.76085.1474
